{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:15:44Z","timestamp":1783091744300,"version":"3.54.6"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007322","name":"Binzhou Medical University","doi-asserted-by":"publisher","award":["2025-L039"],"award-info":[{"award-number":["2025-L039"]}],"id":[{"id":"10.13039\/501100007322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.cellsig.2026.112600","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T11:04:38Z","timestamp":1778756678000},"page":"112600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lysine methyltransferase 5C (KMT5C) promoted malignant growth of prostate cancer through FGFR1\/STAT3 pathway and regulated the immune response"],"prefix":"10.1016","volume":"145","author":[{"given":"Shuhang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lechao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2026.112600_bb0005","first-page":"7","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J. Clin."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112600_bb0010","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112600_bb0015","doi-asserted-by":"crossref","first-page":"24701","DOI":"10.1038\/s41598-024-76158-7","article-title":"Expression and role of CNIH2 in prostate cancer","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112600_bb0020","doi-asserted-by":"crossref","first-page":"2574007","DOI":"10.1080\/15592294.2025.2574007","article-title":"Insight into the mechanisms and dysregulation of KMT5C-H4K20me3 in cancer","volume":"20","author":"Son","year":"2025","journal-title":"Epigenetics"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112600_bb0025","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2024.5633","article-title":"Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis","volume":"64","author":"Zeng","year":"2024","journal-title":"Int. J. Oncol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112600_bb0030","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/HEP.0000000000000559","article-title":"Histone methyltransferase KMT5C drives liver cancer progression and directs therapeutic response to PARP inhibitors","volume":"80","author":"Tong","year":"2024","journal-title":"Hepatology (Baltimore, Md)."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112600_bb0035","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1083\/jcb.201705031","article-title":"SUV420H2 is an epigenetic regulator of epithelial\/mesenchymal states in pancreatic cancer","volume":"217","author":"Viotti","year":"2018","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112600_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052498","article-title":"Impact of histone lysine methyltransferase SUV4-20H2 on cancer onset and progression with therapeutic potential","volume":"25","author":"Papadaki","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112600_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.labinv.2025.104106","article-title":"Lysine methyltransferase 5C (KMT5C) suppresses oral squamous cell carcinoma progression by epigenetic regulation of uridine phosphorylase 1 expression","volume":"105","author":"Zhang","year":"2025","journal-title":"Lab. Invest."},{"issue":"19","key":"10.1016\/j.cellsig.2026.112600_bb0050","article-title":"Targeting KMT5C suppresses lung cancer progression and enhances the efficacy of immunotherapy","volume":"12","author":"Yuan","year":"2025","journal-title":"Adv. Sci. (Weinheim, Baden-Wurttemberg, Germany)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112600_bb0055","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.yexcr.2015.03.010","article-title":"SUV420H2 suppresses breast cancer cell invasion through down regulation of the SH2 domain-containing focal adhesion protein tensin-3","volume":"334","author":"Shinchi","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cellsig.2026.112600_bb0060","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.981226","article-title":"Histone lysine methylation patterns in prostate cancer microenvironment infiltration: integrated bioinformatic analysis and histological validation","volume":"12","author":"Quan","year":"2022","journal-title":"Front. Oncol."},{"issue":"21","key":"10.1016\/j.cellsig.2026.112600_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252111356","article-title":"Unmasking neuroendocrine prostate cancer with a machine learning-driven seven-gene stemness signature that predicts progression","volume":"25","author":"Sabater","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"14","key":"10.1016\/j.cellsig.2026.112600_bb0070","doi-asserted-by":"crossref","first-page":"3880","DOI":"10.1158\/1078-0432.CCR-11-3214","article-title":"Targeting fibroblast growth factor receptor signaling inhibits prostate cancer progression","volume":"18","author":"Feng","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112600_bb0075","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.euo.2021.10.001","article-title":"Fibroblast growth factor receptor 1 drives the metastatic progression of prostate cancer","volume":"5","author":"Labanca","year":"2022","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.cellsig.2026.112600_bb0080","doi-asserted-by":"crossref","DOI":"10.1155\/proc\/8862153","article-title":"Autocrine fibroblast growth factor receptor 1 signaling activates lactate dehydrogenase A-aerobic glycolysis for advanced human prostate tumor growth","volume":"2025","author":"Xu","year":"2025","journal-title":"Prostate Cancer"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112600_bb0085","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.18632\/oncotarget.27957","article-title":"FGFR1, a novel biomarker for metastatic castration-resistant prostate cancer?","volume":"12","author":"Gallo","year":"2021","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.cellsig.2026.112600_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101208","article-title":"FGF9\/FGFR1 promotes cell proliferation, epithelial-mesenchymal transition, M2 macrophage infiltration and liver metastasis of lung cancer","volume":"14","author":"Chang","year":"2021","journal-title":"Transl. Oncol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112600_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics15070873","article-title":"Neuroinflammatory mechanisms of adult sepsis-associated encephalopathy: implications for blood-brain barrier disruption and oxidative stress","volume":"15","author":"Liu","year":"2025","journal-title":"Diagnostics"},{"issue":"8","key":"10.1016\/j.cellsig.2026.112600_bb0100","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1158\/0008-5472.CAN-20-0821","article-title":"Loss of KMT5C promotes EGFR inhibitor resistance in NSCLC via LINC01510-mediated upregulation of MET","volume":"82","author":"Pal","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.cellsig.2026.112600_bb0105","first-page":"1","article-title":"High level of KMT5C is associated to better prognosis and its knockdown increases proliferation in head and neck cancer","author":"Sousa","year":"2025","journal-title":"Epigenomics"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112600_bb0110","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41419-019-1437-0","article-title":"miR-29a contributes to breast cancer cells epithelial-mesenchymal transition, migration, and invasion via down-regulating histone H4K20 trimethylation through directly targeting SUV420H2","volume":"10","author":"Wu","year":"2019","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112600_bb0115","doi-asserted-by":"crossref","first-page":"13131","DOI":"10.3390\/cimb46110783","article-title":"Pharmacological and biological targeting of FGFR1 in Cancer","volume":"46","author":"Fan","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112600_bb0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/med.21288","article-title":"FGF receptors: cancer biology and therapeutics","volume":"34","author":"Katoh","year":"2014","journal-title":"Med. Res. Rev."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112600_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112526","article-title":"STEAP3 promotes triple-negative breast cancer growth through the FGFR1-mediated activation of PI3K\/AKT\/mTOR signaling","volume":"28","author":"Yuan","year":"2025","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112600_bb0130","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s13046-021-02117-z","article-title":"L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1\/SRC\/STAT3 signaling","volume":"40","author":"Giordano","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112600_bb0135","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s12094-022-02918-4","article-title":"TNFAIP3 mediates FGFR1 activation-induced breast cancer angiogenesis by promoting VEGFA expression and secretion","volume":"24","author":"Gao","year":"2022","journal-title":"C. Transl. Oncol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112600_bb0140","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/s41401-018-0191-7","article-title":"C11, a novel fibroblast growth factor receptor 1 (FGFR1) inhibitor, suppresses breast cancer metastasis and angiogenesis","volume":"40","author":"Chen","year":"2019","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112600_bb0145","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1158\/0008-5472.CAN-09-3033","article-title":"Signal transducers and activators of transcription-3 binding to the fibroblast growth factor receptor is activated by receptor amplification","volume":"70","author":"Dudka","year":"2010","journal-title":"Cancer Res."},{"issue":"41","key":"10.1016\/j.cellsig.2026.112600_bb0150","doi-asserted-by":"crossref","first-page":"43162","DOI":"10.18632\/oncotarget.6351","article-title":"SUV420H1 enhances the phosphorylation and transcription of ERK1 in cancer cells","volume":"6","author":"Vougiouklakis","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.cellsig.2026.112600_bb0155","article-title":"Shaping polarization of tumor-associated macrophages in Cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112600_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24087493","article-title":"Tumor-associated macrophage subsets: shaping polarization and targeting","volume":"24","author":"Zhang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"13","key":"10.1016\/j.cellsig.2026.112600_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112600_bb0170","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202414929","article-title":"Manganese galvanic cells intervene in tumor metabolism to reinforce cGAS-STING activation for bidirectional synergistic hydrogen-immunotherapy","volume":"37","author":"Yang","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.cellsig.2026.112600_bb0175","first-page":"248","article-title":"Metal fluoride nanoregulators reverse therapeutic resistance via stemness remodeling to trigger pyroptosis for chemoimmunotherapy","volume":"56","author":"Sun","year":"2026","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.cellsig.2026.112600_bb0180","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jconrel.2021.04.035","article-title":"Alendronate-functionalized hypoxia-responsive polymeric micelles for targeted therapy of bone metastatic prostate cancer","volume":"334","author":"Long","year":"2021","journal-title":"J. Control. Rel."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112600_bb0185","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/s41401-020-0400-z","article-title":"Engineering nanomedicines through boosting immunogenic cell death for improved cancer immunotherapy","volume":"41","author":"Gao","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112600_bb0190","doi-asserted-by":"crossref","first-page":"597","DOI":"10.2174\/0109298665403178250806111943","article-title":"Mevalonate metabolic reprogramming drives cisplatin resistance in bladder Cancer: mechanisms and therapeutic targeting","volume":"32","author":"Fang","year":"2025","journal-title":"Protein Pept. Lett."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826002536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826002536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T14:18:01Z","timestamp":1783088281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826002536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":38,"alternative-id":["S0898656826002536"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112600","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lysine methyltransferase 5C (KMT5C) promoted malignant growth of prostate cancer through FGFR1\/STAT3 pathway and regulated the immune response","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112600"}}